In particular, the pharmacological inhibition of AKR1B1 with Sorbinil not only reduced sorbitol levels but also markedly suppressed NF-κB activation and COX-2 upregulation, directly implicating AKR1B1 in the pro-inflammatory signaling elicited by acute hyperglycemia. The gene discussed is NFKB1; the disease is Hyperglycemia.